Atlas Trials

Phase I Clinical Trial of Adsorbed Tetanus Vaccine

Clinical trial NCT07598890 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07598890
Sponsor
Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Tetanus
Start date
2026-05-21
Primary completion
2026-12-21
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.